Figure 1From: Randomized controlled trial to evaluate the effects of combined progressive exercise on metabolic syndrome in breast cancer survivors: rationale, design, and methods Study design. Endpoints are assessed at baseline (T1), after the end of the 16-week intervention (T2), and 12Â weeks post-intervention (Exercise Group only; T3).Back to article page